Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free BSEM Stock Alerts
NASDAQ:BSEM

Biostem Technologies (BSEM) Stock Price, News & Analysis

$4.18 -0.03 (-0.71%)
Closing price 09/10/2026 04:00 PM Eastern
Extended Trading
$4.26 +0.08 (+2.01%)
As of 07:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Biostem Technologies Stock (NASDAQ:BSEM)

View Price History Chart DataSkip Price History Chart
Advanced
1 Day 5 Days 30 Days 90 Days 1 Year
Advanced

Key Stats

Today's Range
$4.13
▼
$4.30
50-Day Range
$3.00
▼
$4.21
52-Week Range
$2.25
▼
$8.40
Volume
93,788 shs
Average Volume
129,600 shs
Market Capitalization
$74.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

BioStem Technologies, Inc. (NASDAQ: BSEM) is a biotechnology company focused on regenerative medicine and biologic tissue products. Through its operating businesses, the company develops, manufactures and distributes human tissue allografts intended to support wound care, surgical procedures and other regenerative applications.

Its product portfolio includes placental-tissue-based products, including amniotic membrane and related graft technologies. These products are designed for use by health-care professionals in applications such as wound management and tissue repair. BioStem emphasizes the processing and preservation of donated biologic tissues for use in clinical settings.

The company is based in Florida and serves the U.S. health-care market through relationships with medical providers, distributors and other health-care organizations. BioStem Technologies is led by Chief Executive Officer Jason Matuszewski. Additional information about the company’s historical operations and geographic reach is limited, and product availability and indications may vary by applicable regulatory requirements.

AI Generated. May Contain Errors.

Biostem Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

BSEM MarketRank™: 

Biostem Technologies scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Biostem Technologies has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Biostem Technologies has only been the subject of 1 research reports in the past 90 days.

  • Read more about Biostem Technologies' stock forecast and price target.

  • Earnings Growth

    Earnings for Biostem Technologies are expected to grow in the coming year, from ($1.90) to ($1.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Biostem Technologies is -2.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.67% of the float of Biostem Technologies has been sold short.

  • Short Interest Ratio / Days to Cover

    Biostem Technologies has a short interest ratio ("days to cover") of 1.34, which is generally considered an acceptable ratio of short interest to trading volume.

  • Change versus previous month

    Short interest in Biostem Technologies has recently decreased by 78.49%, indicating that investor sentiment is improving significantly.

  • Dividend Yield

    Biostem Technologies does not currently pay a dividend.

  • Dividend Growth

    Biostem Technologies does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Biostem Technologies this week, compared to 4 articles on an average week.

  • Search Interest

    39 people have searched for BSEM on MarketBeat in the last 30 days. This is an increase of 39% compared to the previous 30 days.
Receive BSEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biostem Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BSEM Stock News Headlines

Biostem Technologies (NASDAQ:BSEM) Raised to Sell at Wall Street Zen
September 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31003890
BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
September 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/04/3356492/0/en/biostem-technologies-opens-hospital-access-for-vendaje-and-vendaje-ac-through-vizient-and-premier.html
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
September 11 at 1:00 AM  |  Profits Run (Ad)
BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/03/3356241/0/en/biostem-technologies-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference.html
See More Headlines

BSEM Stock Analysis - Frequently Asked Questions

Biostem Technologies' stock was trading at $3.9090 at the beginning of the year. Since then, BSEM shares have increased by 6.9% and is now trading at $4.18.

Shares of BSEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
9/11/2026
Fiscal Year End
12/31/2026
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:BSEM
CIK
1658678
Web
N/A
Phone
(954) 380-8342
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$47.48 million
Price / Sales
1.57
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
17,850,000
Free Float
N/A
Market Cap
$74.61 million
Optionable
N/A
Beta
0.12
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NASDAQ:BSEM) was last updated on 9/11/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel